Tirzepatide ameliorates spatial learning and memory impairment through modulation of aberrant insulin resistance and inflammation response in diabetic rats
Special considerations in older adults Ruchi Gaba, MD, an associate professor of endocrinology at Baylor College of Medicine in Houston, says that she thinks about multiple factors before prescribing GLP-1s for her patients 65 and older
NNC0090-2746 (RG7697) is a compound that has been tested in multiple preclinical and clinical studies as a dual GIPR/GLP-1R agonist [58,59,60]
In the US, there is now an FDA-approved oral version of Wegovy for chronic weight management, and there is also Rybelsus, an oral semaglutide medication approved for adults with type 2 diabetes
Brand Vyvanse either moved to non-preferred Tier 3 or fell off formularies entirely, with some plans requiring prior authorization to cover the brand when a generic is available
Most people who stop using GLP-1s regain the weight they lost, even with sustained lifestyle changes